Printer Friendly

Paradigm Medical Industries Introduces Advances on the LD400 Full-Field Autoperimetry System.

SALT LAKE CITY -- Paradigm Medical Industries, Inc. (OTCBB: PMED.OB), a leader in glaucoma diagnostic and management devices, is introducing new advance developments to the Paradigm-Dicon LD400 full-field autoperimetry system. The LD400 is used to measure patient visual fields to determine the severity of glaucoma and to aid in managing the disease.

"The Company has redesigned what we believe to be the industry's superior autoperimeter," said Paradigm Medical's Chief Executive Officer, Raymond Cannefax. "Demand for our proprietary Paradigm-Dicon LD400 product continues to be extremely high in the U.S. and globally, and this updated product incorporates all the changes the medical profession has requested. We believe we are also broadening the market for autoperimeters.

"The kinetic fixation feature of the LD400 Autoperimeter is unique and exclusive to perimetry and offers full kinetic fixation for greater reliability, improved test results and patient comfort," Mr. Cannefax added. "Kinetic fixation reduces patient fatigue and increases patient interest resulting in higher exam accuracy. The Paradigm-Dicon LD400 provides the highest standard of care from a full-field autoperimeter."

New developments to the LD400 include redesigning the existing software, assuring device compatibility with a variety of printers and making the device fully networkable. All connections will be through USB ports. The patient data base will be similar to the Paradigm P60 Ultrasound BioMicroscope (UBM) and the printed examination reports will be grayscale, making them much easier to read.

Paradigm Medical Industries, Inc., is a leader in Ultrasound devices, and glaucoma detection and management products.

This press release contains statements that, if not verifiable historic fact, may be viewed as forward-looking statements that could predict future events and outcomes with respect to Paradigm and its business. The predictions embodied in these statements will involve risk and uncertainty and, accordingly, actual results may differ significantly from the results discussed or implied in such forward-looking statements.
COPYRIGHT 2008 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Mar 5, 2008
Words:306
Previous Article:Maggie Rubey Lynch Promoted to Senior Vice President, Worldwide Recruitment & Executive Search, Time Warner Inc.
Next Article:Medical Staffing Network Holdings Announces Fourth Quarter and Fiscal Year 2007 Operating Results.


Related Articles
Paradigm Medical Acquires Leading Producer of Equipment Used in Refractive Procedures.
Paradigm Licenses Destinator -TM- Software to Viasat S.p.A., the Joint Venture Between Fiat and Telecom Italia Mobility.
Paradigm Medical's Upgraded LD400 FT Cuts Diagnostic Time for Autoperimetry by over 40%.
Paradigm Medical Industries to Introduce Several New Instruments at AAO Convention.
Paradigm Medical Industries Announces Operations and Sales Management Reorganization.
Paradigm Medical Industries Developing New Software for P60 UBM Device.
Paradigm Medical Industries Receives Major LD400 Perimeter Order from Large Optical Chain in United Kingdom.
Paradigm Medical Industries Completes $1 Million Financing.
Paradigm Medical Industries to Introduce Early Glaucoma Detection Device at ASCRS Conference.

Terms of use | Copyright © 2014 Farlex, Inc. | Feedback | For webmasters